Single-center experience of 309 consecutive patients with obscure gastrointestinal bleeding

Table 3 CE diagnostic yields of massive bleeding and chronic recurrent bleeding n (%)

Type of lesion	All	Massive bleeding	Chronic recurrent overt bleeding
Angioectasias (Figure 2)	49 (28.3)	6 (22.2)	43 (29.9)
SB tumor	53 (30.6)	15 (51.7)	38 (26.0)
Mesenchymoma (Figure 3)	15 (8.7)	5 (17.2)	10 (6.9)
Polyps	13 (7.5)	2 (6.9)	11 (7.6)
Hemangioma (Figure 4)	6 (3.5)	2 (6.9)	4 (2.8)
Lipoma	4 (2.3)	0 (0)	4 (2.8)
Lymphoma (Figure 5)	4 (2.3)	2 (6.9)	2 (1.4)
BRBNS	2 (1.2)	2 (6.9)	0 (0)
Adenoma	1 (0.6)	1 (3.5)	0 (0)
Metastatic melanoma	1 (0.6)	0 (0)	1 (1.4)
Mass	7 (4.0)	1 (3.5)	6 (4.2)
Crohn’s disease (Figure 6)	25 (14.5)	2 (6.9)	23 (16.0)
Ulcer	15 (8.7)	2 (6.9)	13 (9.0)
Multiple ulcer	11 (6.4)	1 (3.5)	10 (7.6)
Isolated ulcer	4 (2.3)	1 (3.5)	3 (2.1)
SB verminosis	12 (6.9)	2 (6.9)	10 (6.9)
Non-specific enteritis	10 (5.8)	0 (0)	10 (6.9)
SB diverticulum	7 (4.0)	1 (3.5)	6 (4.2)
SAME	1 (0.6)	1 (3.5)	0 (0)
Portal hypertension SB disease	1 (0.6)	0 (0)	1 (1.4)
Total	173	29	144

SAME: Superior mesenteric artery embolus; SB: Small bowel; BRBNS: Blue rubber bleb nevus syndrome.